Loading...
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it has remained the drug of choice in treatment-resistant schizophrenia, despite a wide range of adverse effects, as it is a ve...
Na minha lista:
| Udgivet i: | Ther Adv Drug Saf |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956953/ https://ncbi.nlm.nih.gov/pubmed/29796248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098618756261 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|